IOL Chemicals and Pharmaceuticals informs about updates

15 Oct 2025 Evaluate
In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, IOL Chemicals and Pharmaceuticals has informed that the European Directorate for the Quality of Medicines & Health Care (EDQM) has issued a Certificate of Suitability for Company’s API product ‘Pantoprazole Sodium Sesquihydrate Process-III’ on 14th October 2025. Pantoprazole sodium is a proton pump inhibitor (PPI) that reduces stomach acid and is used to treat conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome.

The above information is a part of company’s filings submitted to BSE.

IOL Chem & Pharma Share Price

74.47 -1.11 (-1.47%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×